1. Home
  2. POWL vs NAMS Comparison

POWL vs NAMS Comparison

Compare POWL & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Industries Inc.

POWL

Powell Industries Inc.

HOLD

Current Price

$498.50

Market Cap

4.0B

Sector

Energy

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$28.76

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POWL
NAMS
Founded
1947
2019
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.5B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
POWL
NAMS
Price
$498.50
$28.76
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$427.00
$46.75
AVG Volume (30 Days)
194.3K
804.5K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
0.21%
N/A
EPS Growth
20.91
N/A
EPS
3.40
N/A
Revenue
$448,716,000.00
N/A
Revenue This Year
$9.66
$25.64
Revenue Next Year
$6.61
$530.85
P/E Ratio
$151.23
N/A
Revenue Growth
13.34
N/A
52 Week Low
$153.30
$14.06
52 Week High
$612.50
$42.00

Technical Indicators

Market Signals
Indicator
POWL
NAMS
Relative Strength Index (RSI) 46.42 34.30
Support Level $476.00 $23.48
Resistance Level $612.50 $37.43
Average True Range (ATR) 27.78 1.77
MACD -7.66 -0.42
Stochastic Oscillator 23.91 0.75

Price Performance

Historical Comparison
POWL
NAMS

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: